FACCHINETTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 48
NA - Nord America 13
AS - Asia 8
Totale 69
Nazione #
IT - Italia 28
US - Stati Uniti d'America 11
DE - Germania 9
SG - Singapore 4
FI - Finlandia 3
CA - Canada 2
CH - Svizzera 2
RO - Romania 2
ES - Italia 1
FR - Francia 1
GB - Regno Unito 1
IN - India 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
TR - Turchia 1
Totale 69
Città #
Casina 11
Bremen 9
Correggio 3
Helsinki 3
Pisa 3
Rome 3
Bacau 2
Elkins Park 2
Milan 2
Padova 2
Toronto 2
Arlington 1
Baltimore 1
Enschede 1
Gaithersburg 1
Iseo 1
Istanbul 1
London 1
Los Angeles 1
Mashhad 1
New Delhi 1
Orlando 1
Roncoferraro 1
San Diego 1
Suitland 1
Tacoma 1
Urbino 1
Vigo 1
Totale 59
Nome #
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination, file e177fbc7-a6a3-50b0-e053-d805fe0adaee 29
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors, file e177fbc7-9e55-50b0-e053-d805fe0adaee 15
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: A systematic review and meta-analysis, file e177fbc7-a766-50b0-e053-d805fe0adaee 4
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors, file e177fbc7-a7af-50b0-e053-d805fe0adaee 4
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib, file e177fbc7-a358-50b0-e053-d805fe0adaee 3
Exploring the role of respiratory microbiome in lung cancer: A systematic review, file e177fbc7-aae6-50b0-e053-d805fe0adaee 3
Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?, file e177fbc8-0437-50b0-e053-d805fe0adaee 3
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy, file e177fbc7-a416-50b0-e053-d805fe0adaee 2
Cystic brain metastases and RET fusion in lung cancer, file e177fbc7-a54d-50b0-e053-d805fe0adaee 2
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: A systematic review and meta-analysis, file e177fbc7-a9c4-50b0-e053-d805fe0adaee 2
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib, file e177fbc7-a7bb-50b0-e053-d805fe0adaee 1
Osimertinib in CNS-progressive EGFR-mutant lung cancer: do we need to detect T790M?, file e177fbc7-a7bd-50b0-e053-d805fe0adaee 1
Totale 69
Categoria #
all - tutte 136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0000 00 110 21003
2022/202343 65011 100 110 0000
Totale 69